(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Quarter results tomorrow
(tns 2024-05-06)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada...
Stats | |
---|---|
आज की मात्रा | 11 680.00 |
औसत मात्रा | 3 003.00 |
बाजार मूल्य | 5.74M |
EPS | $0 ( 2024-02-12 ) |
अगली कमाई की तारीख | ( $0 ) 2024-05-06 |
Last Dividend | $0.500 ( 2008-08-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.53 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-28 | Riva Sheppard | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Kay Christina | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Masi Dina | Buy | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
84.20 |
Last 98 transactions |
Buy: 38 374 999 | Sell: 953 334 |
Integrated BioPharma, सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Integrated BioPharma, वित्तीय
Annual | 2023 |
राजस्व: | $50.67M |
सकल लाभ: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
FY | 2023 |
राजस्व: | $50.67M |
सकल लाभ: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
FY | 2023 |
राजस्व: | $0 |
सकल लाभ: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
राजस्व: | $56.25M |
सकल लाभ: | $6.55M (11.65 %) |
EPS: | $0.130 |
Financial Reports:
No articles found.
Integrated BioPharma, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 2008-08-19 |
Last Dividend | $0.500 | 2008-08-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.500 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.59 | -- |
Div. Sustainability Score | 2.86 | |
Div.Growth Potential Score | 0.996 | |
Div. Directional Score | 1.930 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
FULO | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
EMYB | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
CBKM | Ex Dividend Knight | 2023-08-18 | Quarterly | 0 | 0.00% | |
TNCAF | Ex Dividend Junior | 2023-08-30 | Quarterly | 0 | 0.00% | |
RSKIA | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
NIPNF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
FMCB | Ex Dividend Knight | 2023-06-08 | Semi-Annually | 0 | 0.00% | |
CSBB | Ex Dividend Knight | 2023-09-01 | Quarterly | 0 | 0.00% | |
WCRS | Ex Dividend Junior | 2023-08-21 | Quarterly | 0 | 0.00% | |
SFDL | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00615 | 1.500 | -0.123 | -0.185 | [0 - 0.5] |
returnOnAssetsTTM | -0.0150 | 1.200 | -0.499 | -0.599 | [0 - 0.3] |
returnOnEquityTTM | -0.0205 | 1.500 | -1.339 | -2.01 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.93 | 0.800 | 0.372 | 0.298 | [1 - 3] |
quickRatioTTM | 0.765 | 0.800 | -0.203 | -0.162 | [0.8 - 2.5] |
cashRatioTTM | 0.125 | 1.500 | -0.414 | -0.621 | [0.2 - 2] |
debtRatioTTM | 0.0884 | -1.500 | 8.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -27.32 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.122 | -1.500 | 9.51 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0535 | 1.000 | -2.44 | -2.44 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0109 | 1.000 | -2.22 | -2.22 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.125 | 1.000 | -0.419 | -0.419 | [0.2 - 2] |
assetTurnoverTTM | 2.43 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 2.86 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -14.90 | 1.000 | -1.606 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0205 | 2.50 | -0.861 | -2.01 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.110 | 1.500 | -2.60 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00453 | 1.000 | -2.39 | 0 | [0.1 - 0.5] |
Total Score | 0.996 |
Integrated BioPharma,
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं